Abstract: The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.

Abstract: A technology for producing a pig edema disease vaccine at low cost and at high efficiency is developed. Specifically, a gene of a pig edema disease toxin protein (Stx2e protein) is efficiently expressed in plant cells to produce a plant vaccine for pig edema disease at low cost. An Stx2e protein including a secretory signal peptide derived from a plant added at an amino terminus is expressed in cells of a plant such as Lactuca sativa using the 5?-untranslated region of an alcohol dehydrogenase gene (ADH5?UTR) derived from a plant.

Abstract: The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.

Abstract: It is an object of the invention to discover a substance that effectively increases the production of adrenomedullin, as well as to provide an adrenomedullin production-enhancing agent utilizing this substance. The adrenomedullin production-enhancing agent is characterized by inclusion of a ginsenoside, a sanshool, and/or a shogaol as active ingredients.

Abstract: There is provided a zero-voltage switching high-frequency inverter capable of supplying a current of a large amplitude operation to a load, while suppressing a main switch current. The zero-voltage switching high-frequency inverter according to the present invention comprises: a first switch S1 and a second switch S2 that are connected in series between power sources Ed; a first capacitor C1, an impedance element R, and an inductor element L that are connected in series between a connecting path connecting the first switch S1 and the second switch S2 and one end of the power sources Ed; and a second capacitor C2 connected in parallel to the impedance element R and the inductor element L that are connected in series.

Abstract: There is provided a zero-voltage switching high-frequency inverter capable of supplying a current of a large amplitude operation to a load, while suppressing a main switch current. The zero-voltage switching high-frequency inverter according to the present invention comprises: a first switch S1 and a second switch S2 that are connected in series between power sources Ed; a first capacitor C1, an impedance element R, and an inductor element L that are connected in series between a connecting path connecting the first switch S1 and the second switch S2 and one end of the power sources Ed; and a second capacitor C2 connected in parallel to the impedance element R and the inductor element L that are connected in series.

Abstract: A dental composition for oral use, containing a phosphorylated saccharide (a), a cationic bactericidal agent (b) and a solvent (c). By using the dental composition for oral use of the present invention, the adhesion of the bacteria in the oral cavity to the surfaces of the teeth can be suppressed for a long period of time; therefore, the dental composition for oral use can be suitably used for, for example, a mouse-wash agent, a dentifrice agent, a gargling agent, a mouse spray, a coating agent or a bonding agent to tooth surface or a dental prosthetic, a hypersensitive inhibitor, a therapeutic agent for periodontal diseases, that is applied to a periodontal pocket, or the like.

Abstract: The objectives are to find a substance or a composition capable of promoting the production of ghrelin with physiological activities such as growth hormone secretion effect, and to provide a pharmaceutical comprising it as the active ingredient. The pharmaceutical is a ghrelin production promoter comprising Rikkunshi-to as the active ingredient.

Abstract: A structural framework assembly made up of tubular members interconnected by a first connector arrangement which uses a connector having a concave surface pressing against a curved outer surface of a tubular member and having a pair of spreadable arms which are spread by a setscrew to lock inside an end of another tubular member, and a second connector arrangement which uses a connector plate extending into the end of a tubular member with the bottom of the connector plate inserted into a longitudinal slot at the bottom of the tubular member and a top tab on the connector plate inserted into an upper slot at the top of the tubular member. The longitudinal slot at the bottom of the tubular member opens out to the end of the tubular member and the upper slot is located at a distance from the end of the tubular member.

Abstract: A structural framework assembly (150) is made up of framework subassemblies (102, 104, 104', etc.) interconnected by elongated horizontal structural members (122, 124, 126, 128, etc.). The subassemblies are made up of elongated structural members (114, 116, 118, 120) interconnected by clamping assemblies (106, 108, 110, 112). The clamping assemblies are made up of clamp elements (20a, 20b) with recesses (28, 30) which extend part way around the structural members and third portions (26) with cylindrical recesses (36) in which the ends of other elongated structural members are locked.